BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 73 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $1,418,600 | 1.09% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $875,214 | 0.93% |
| TANG CAPITAL MANAGEMENT LLC | 3,812,773 | $2,859,580 | 0.29% |
| Acuitas Investments, LLC | 630,507 | $472,880 | 0.25% |
| Vivo Capital, LLC | 3,521,291 | $2,640,968 | 0.24% |
| Newtyn Management, LLC | 1,363,234 | $1,022,425 | 0.19% |
| Samsara BioCapital, LLC | 1,049,153 | $786,865 | 0.16% |
| Sofinnova Investments, Inc. | 2,754,437 | $2,065,828 | 0.11% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $539,659 | 0.04% |
| ADAR1 Capital Management, LLC | 185,999 | $139,499 | 0.03% |